共 16 条
ORAL TREATMENT WITH PBI-4547, A NOVEL FIRST-IN-CLASS ANTI-DIABETIC AND ANTI-FIBROTIC COMPOUND, IMPROVES GLOMERULAR FUNCTION AND PREVENTS PODOCYTE INJURY IN THE DIABETIC DB/DB MOUSE MODEL
被引:0
|作者:
Grouix, Brigitte
[1
]
Hince, Kathy
[1
]
Sarra-Bournet, Franois
[1
]
Felton, Alexandra
[1
]
Tremblay, Mikael
[1
]
Cloutier, Marie-Pier
[1
]
Abbott, Shaun
[2
]
Duceppe, Jean-Simon
[2
]
Zacharie, Boulos
[2
]
Laurin, Pierre
[1
]
Gagnon, Lyne
[1
]
机构:
[1] ProMet BioSci Inc, Biol, Laval, PQ, Canada
[2] ProMet BioSci Inc, Chem, Laval, PQ, Canada
关键词:
D O I:
10.1093/ndt/gfv188.10
中图分类号:
R3 [基础医学];
R4 [临床医学];
学科分类号:
1001 ;
1002 ;
100602 ;
摘要:
SP047
引用
收藏
页数:1
相关论文